Koliber Biosciences — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

Overview

Koliber Biosciences is a private, pre-revenue biotechnology company that combines machine learning/AI expertise with deep biological domain knowledge to offer both service-based solutions and develop proprietary technology platforms. Its core assets include an AI platform for peptide drug discovery, funded by the NSF, and a genetic toolkit for engineering Lactobacillus species, funded by an NIH SBIR grant. The company's business model is hybrid, encompassing fee-for-service consulting in data science and statistics while advancing internal platform technologies with the potential for therapeutic or tool licensing.

Neuroscience

Technology Platform

AI/ML platform for peptide drug discovery and a genetic engineering toolkit for Lactobacillus species in the microbiome.

Opportunities

The company is positioned at the convergence of two high-growth fields: AI-driven drug discovery and microbiome engineering.

Its ability to work with smaller datasets for peptide design addresses an unmet need for many biotechs.

Successful early-access partnerships could lead to lucrative licensing deals and validate its platforms for broader adoption.

Risk Factors

Key risks include the technological validation of its AI platform in generating clinically relevant leads, intense competition from larger, well-funded AI-biotech firms, and the challenge of transitioning from a grant-funded service model to a scalable product/IP licensing company.

Securing subsequent venture funding is critical.

Competitive Landscape

Koliber competes in the AI drug discovery space against large public companies (e.g., Recursion, Exscientia) and numerous startups, and in the microbiome tools space against synthetic biology firms. Its differentiation lies in its specific focus on peptides and Lactobacillus engineering, and its hybrid service-and-platform model which provides early market insight.

More companies in AI / Machine Learning →More companies in United States →